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MicroRNAs (miRNAs) have been shown to play important roles in both brain development and the regulation of adult neural cell
functions.However, a systematic analysis of brainmiRNAfunctionshasbeenhinderedbya lackof comprehensive information regarding
the distribution ofmiRNAs in neuronal versus glial cells. To address this issue, we performedmicroarray analyses ofmiRNA expression
in the four principal cell types of the CNS (neurons, astrocytes, oligodendrocytes, andmicroglia) using primary cultures from postnatal
d 1 rat cortex. These analyses revealed that neural miRNA expression is highly cell-type specific, with 116 of the 351 miRNAs examined
being differentially expressed fivefold or more across the four cell types. We also demonstrate that individual neuron-enriched or
neuron-diminished RNAs had a significant impact on the specification of neuronal phenotype: overexpression of the neuron-enriched
miRNAsmiR-376a andmiR-434 increased the differentiation of neural stem cells into neurons, whereas the opposite effect was observed
for the glia-enriched miRNAs miR-223, miR-146a, miR-19, and miR-32. In addition, glia-enriched miRNAs were shown to inhibit
aberrant glial expression of neuronal proteins and phenotypes, as exemplified by miR-146a, which inhibited neuroligin 1-dependent
synaptogenesis. This study identifies new nervous system functions of specificmiRNAs, reveals the global extent to which the brainmay
use differentialmiRNAexpression to regulate neural cell-type-specific phenotypes, andprovides an important data resource that defines
the compartmentalization of brain miRNAs across different cell types.
Introduction
MicroRNAs (miRNAs) are 19- to 24-nucleotide (nt) noncoding
RNAs that act as important regulators of posttranscriptional gene
expression (Ambros, 2004; Kim, 2005). miRNAs bind tomessen-
ger RNAs (mRNAs) based on sequence complementarity and
direct the degradation or repression of translation of the mRNAs
to which they are bound (known as their targets). Typically, a
miRNA can bind to many targets and each target may be regu-
lated by multiple miRNAs.
Recent studies have shown that numerous miRNAs exist in
mammalian systems, where they play important roles in develop-
ment, are responsible for regulating cell-type-specific functions
in the adult organism, and are involved in disease processes
(Bartel, 2009). Interestingly, miRNAs show varying levels in dif-
ferent organs, which is consistent with their anticipated role in
regulating tissue-specific protein expression (Lagos-Quintana et
al., 2002). Compared with other organs, the brain has a particu-
larly high percentage of tissue-specific and tissue-enriched miR-
NAs (Lagos-Quintana et al., 2002; Kim et al., 2004; Sempere et al.,
2004; Smirnova et al., 2005). The physiological importance of
miRNAs in nervous system functions and disease states has also
been suggested by previous studies of a small number of brain-
enrichedmiRNAs (Leucht et al., 2008;Mellios et al., 2008; Packer et
al., 2008; Cheng et al., 2009; Schratt, 2009). However, the full scope
of miRNA-mediated regulation of brain functions is largely un-
known. Contributing to the limitations in current knowledge was
the lack of data on brainmiRNA expression at the cellular level.
Neural tissue is highly heterogeneous, being composed of differ-
ent types of neurons, astrocytes, and oligodendrocytes, which de-
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velop from a common pool of neural progenitor cells (Gage, 2000),
andmicroglia,whichdevelop fromthehematopoietic lineage (Ritter
et al., 2006). The heterogeneous phenotypes of the various neural
cellsmust be established during cell specification and bemaintained
throughout the life of the adult organism. To better understand the
extent towhichbrainmiRNAsmight govern specific cellular pheno-
types, we sought to establish and quantify differences in miRNA
expression across the four neural cell subtypes. We then proceeded
to test the hypothesis that cell-type-specificmiRNA expression con-
tributes to neural cell specification andmaintenance.
Consistent with our hypothesis, our analyses showed that neural
cell subtypes differed extensively in their miRNA expression pat-
terns. Functional testing of the newly identified cell-type-specific
miRNAs also indicated that cell-type-specificmiRNAsparticipate in
the specification of neuronal versus glial fates. Moreover, we have
implicated a number of new miRNAs in the regulation of cell type
specification by showing that neuron-specific miRNAs promoted
and glia-specific miRNAs inhibited neuronal differentiation. In ad-
dition, we show that glial miRNAs are capable of targeting neuron-
specific mRNAs and may thereby prevent inappropriate glial
expression of neuronal proteins and phenotypes.
In addition to identifying new roles of specific brain miRNAs,
our data represent a valuable resource that delineates the relative
levels of miRNA expression in each of the four neural cell types.
These data and analyses support further study of brain miRNAs
that may have important nervous system functions.
Materials andMethods
Cell cultures. Primary cultures were prepared in accordance with the Euro-
pean Community directive for the care and use of laboratory animals (86/-
609/-EEC) and the Swiss Academy of Medical Science and with the
authorization (1667.2) of the veterinary office of the canton of Vaud. Disso-
ciatedneuronal andglial cultureswereprepared fromcortexes of postnatal d
1 (P1) rats (of both sexes). To obtain neuronal cultures, cells were grown in
neurobasal medium supplemented with B-27 (Invitrogen) and cytosine ar-
abinoside. To obtain glial cells, mixed cortical cultures were grown in basal
minimum Eagle’s medium (BMEM, Invitrogen) supplemented with 10%
fetal calf serum, 0.36% glucose, 0.5 mM glutamine, and 1 penicillin-
streptomycin (Invitrogen). After 10–14 d in vitro, microglial cells were col-
lected from themediumof themixed culture. To eliminate loosely adherent
microglia andneurons,mixed cultureswere shakenona rotary shaker at 300
rpm for 30 min, after which the medium was replaced. Oligodendrocyte
progenitor cells were collected from the medium of cultures shaken over-
night. These were plated onto poly-L-lysine-coated plates and grown in dif-
ferentiation medium comprising DMEM-Ham’s F12 (DMEM-F12)
supplemented with 10% fetal calf serum, 0.36% glucose, 0.5mM glutamine,
and 1 penicillin-streptomycin (Invitrogen). The remaining cells attached
to the original culture dish shaken overnight comprised astrocytes. Addi-
tional procedural details and additional cellular characterization data can be
found in Kuhn et al. (2011).
Rat cortical stem cells were obtained from D&B Biosciences (catalog
#NSC001) and handled according to the supplier’s instructions. Upon re-
ception, cells were plated in DMEM/F-12 with N-2 supplement, basic FGF
(20 ng/ml), and L-glutamine (1 mM) on poly-L-ornithine- and fibronectin-
coated plates. Fresh FGF was added to the culture daily. One day after plat-
ing, cells were infected with lentiviral expression vectors. Three days after
lentiviral exposure, differentiation was induced by FGF withdrawal, chang-
ing the medium to neurobasal with B-27 supplement (Invitrogen), 1
penicillin-streptomycin (Invitrogen), and 0.5 mM L-glutamine.
RNA isolation and qPCR analysis. Total RNA used for the qPCR anal-
yses was isolated using the Ambion mirVana system. Reverse transcrip-
tion for miRNA analyses in primary cultures and mouse brain was
conducted using TaqMan miRNA assays and TaqMan miRNA reverse
transcription kits (AppliedBiosystems). Reverse transcription formRNA
analysis was performed using the High-Capacity cDNAArchive Kit (Ap-
plied Biosystems). The resultant cDNA was stored at20°C.
Gene expressionmeasures were recorded from triplicate culture samples,
each of which were analyzed by triplicate qPCR assays. TaqMan assays were
performed on a 7900HTReal-Time PCR System and analyzedwith SDS 2.3
software (AppliedBiosystems).Measurement ofmiRNAs in cell lines (PC12
or C6) were performedwithQuantimir assays and reagents (System Biosci-
ences). Relative expression (V) was calculated by Ct corrected for amplifi-
cationefficiencies asdescribed inZuckeret al. (2005),usingnormalization to
sno-U6, -3 tubulin (Tubb3), or -actin (Actb) expression, as indicated.
PCR amplification efficiencies were calculated from standard curves with
total RNA input amounts ranging between 10 ng and 10g using the equa-
tion Ex 10(1 slope) 1.
miRNAmicroarray sampleprocessing. Sampleswerepreparedaccording to
themiRNAMicroarray Systemprotocol (Agilent Technologies). Total RNA
(100 ng) from neurons (N), oligodendrocytes (O), astrocytes (A), and mi-
croglia M (three biological replicates for N, O, and M samples and four
replicates for A samples) were dephosphorylated with calf intestine alkaline
phosphatase (GE Healthcare Europe), denatured with dimethyl sulfoxide,
and labeled with pCp-Cy3 using T4 RNA ligase (GE Healthcare Europe).
The labeled RNAs were hybridized to Agilent Technologies rat miRNAmi-
croarrays (Design ID 019159) for 20 h at 55°C with rotation. After hybrid-
ization and washing, the arrays were scanned with an Agilent Technologies
microarray scanner using high-dynamic-range settings as specified by the
manufacturer. Agilent Technologies’s feature extraction software was used
to collect the data. The microarray signals were then quantile normalized
using GeneSpring software (Agilent Technologies).
Identification of differentially expressed miRNAs. Differentially ex-
pressed miRNAs were identified using the Bioconductor package
“limma” (Wettenhall and Smyth, 2004). A statistical model specifying
the four cell types (A, N, O, and M) as factors was used. All pairwise
comparisons between the four groups were extracted from the model as
contrasts (O vs N, O vs A, N vs A, O vs M, A vs M, N vs M). These six
contrasts were combined into one F test (analogous to a one-way
ANOVA for each gene). P values from the F test were adjusted for mul-
tiple testing with Benjamini and Hochberg’s method to control the false
discovery rate (FDR). To be called differentially expressed, a gene had to
meet the following four criteria: (1) a FDR 1% (F test), (2) aminimum
of fivefold change versus the average expression in the other groups, (3)
a minimum of twofold change versus each of the other groups taken
individually, and (4) an miRNA called enriched in a particular cell type
was called present in all replicates of this group and if a gene was called
diminished in a particular cell type, it should be called present in all
replicates of the other cell type groups. Gene Ontology (GO) analyses of
differentially expressed miRNAs were conducted using the NCBI’s on-
line DAVID bioinformatics interface (Huang et al., 2008, 2009).
Antagomir experiments. Locked nucleic modified antagomirs were
used to knock down expression ofmiRNAs (anti-miR-223:GGGGTATT
TGACAAACTGACA, anti-miR-19a: (TCAGTTTTGCATAGATTTGC
ACA, anti-miR-376a: ACGTGGATTTTCCTCTACGAT, anti-miR-434:
AGGAGTCGAGTGATGGTTCAAAandanti-miR-124:GGCATTCACC
GCGTGCCTTA). The modified positions are indicated in bold letters.
The antagomirs, at a 40 nM concentration, were transfected into PC12
(neuronal) and C6 (glial-like) cell lines to target neuronal (miR-376a,
miR-434,miR-124) and glial (miR-223,miR-19a)miRNAs, respectively.
Both cell lines were also treated with a control antagomir (ACCAATC-
Figure 1. Distribution of neural cell-type-specific mRNAs in primary cultures. To verify the
identity and purity of separated primary neural cells, levels of known cell-type-specific mRNAs
were measured by qPCR normalized to-actin. A, Tubb3. B, Gfap. C, Mbp. D, Itgam. Error bars
represent SD. N, Neuronal cultures; A, astroglial cultures; O, oligodendroglial cultures; M, mi-
croglial cultures; and rel. mRNA abund., relative mRNA abundance.
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GACCAAC). In cotransfection experiments, luciferase–3-UTR clones
were transfected along with respective anti-miRNAs. Twenty-four hours
after transfection, cells were lysed in 20 l of lysis buffer (Promega). The
luciferase assay was performed using a dual-luciferase assay kit (catalog
#E1960; Promega) and Renilla luciferase was normalized to the untar-
geted firefly luciferase.
Fluorescence-activated cell sorting (FACS) of Thy1 and Gfap cells
from mouse brain. Brain tissue was collected from 2 male and 2 female
3-week-old C57BL/6-Tg (Thy1-EGFP) mice and 3 male 3-week-old
C57BL/6-Tg (Gfap-EGFP) mice. Dissociation of cortex and FACS were
performed as described previously (Be´langer et al., 2011). As we have
shown in recent cell-resolved analyses of brain tissue, brain parenchyma
is principally composed of the 4 neural cell types (neurons, astrocytes,
oligodendrocytes, and microglia), with insignificant contributions from
endothelial cells, pericytes, fibroblasts, smooth muscle cells, and eryth-
rocytes (Kuhn et al., 2011).
Synapse formation assay. A synapse formation assay originally devel-
oped by Scheiffele et al. (Scheiffele et al., 2000) was used here. This assay
examines the synaptogenic activity of an individual gene (or protein). In
our implementation of the assay, the cDNA encoding the postsynaptic
protein neuroligin 1 was transfected into astrocytes and the effect of
miR-146a-mediated regulation of the neuroligin 1-dependent activity
was tested. Astrocytes were prepared from P1 rat cortex and plated on
poly-L-lysine-coated coverslips. After astrocytes reached confluence, len-
tiviral expression vectors were used to express neuroligin 1 within the
cells. Ten days after lentiviral transduction, neurons prepared from E16
rat cortex were plated on astrocytes at a plating density of 100 cells per
well in a 24-well plate. (This low density avoids neuron-to-neuron con-
tacts and neuron-to-neuron synapse formation). Forty-eight hours after
the plating of neurons, cells were fixed with 4% paraformaldehyde and
further analyzed using immunolabeling andmicroscopic image analysis.
Synapse formation was analyzed by counting neuronal presynapses,
which were identified by Synapsin 1/2 immunolabeling.
Immunolabeling and microscopic image analyses. Cell cultures were
washed with cold PBS and fixed with 4% paraformaldehyde (Fluka) for
15 min at room temperature. Cultures were subsequently washed with
PBS and incubated in a blocking solution of PBS with 10% normal goat
serum (NGS) (DakoCytomation) and 0.1% Triton X-100 (Sigma). Cells
were then incubated overnight at 4°C in blocking solution containing the
following primary antibodies: mouse monoclonal anti-neuronal nuclei
(NeuN) (1:1000, MAB377 clone A60; Millipore), mouse monoclonal anti-
neuronal class III tubulin (1:500, TUJ1; Covance), rabbit polyclonal anti-
Synapsin 1/2 (1:500, Synaptic Systems), or mouse monoclonal anti-nestin
(1:100, BD Biosciences). Secondary antibodies coupled to fluorophores
(goat anti-mouse IgGAlexaFluor488, goat anti-mouse IgGAlexaFluor594,
goat anti-rabbit IgG Alexa Fluor 594, and goat anti-rabbit IgG Alexa Fluor
488, all 1:800; Invitrogen) were applied for 1 h at room temperature.
Images of differentiated stem cell cultures were acquired with a BD Bio-
sciencesPathway855bioimaging systemandcellswere countedwith ImageJ
software (Rasband, 1997; Abramoff et al., 2004). Images for quantitative
analyseswere acquired under nonsaturating exposure conditions. Stemcells
for Pathway 855 analyses were plated in 96-well plates, avoiding the wells in
the outermost rows and columns. In stem cell differentiation experiments,
15 replicatewells were analyzed per condition, and the effect of amiRNAon
stem cell differentiation was confirmed in a minimum of 3 independent
experiments. The statistical significance of the differences between the
miRNA overexpression condition and the control condition was tested us-
ing unpaired Student’s t test.
Images of cell cultures for synapse formation assays were acquired
using a Leica confocal microscope.
4
Figure2. DifferentialmiRNA expression across the four neural cell types. The four neural cell
types differ extensively in their miRNA expression profiles. O indicates oligodendrocytes; M,
microglia; N, neurons; and A, astrocytes. Scale bar shows the fold change in the miRNA
expression in one sample compared with the average expression value in the others. A
corresponding table with the means SD of microarray measures of expression in the
four cell types is available upon request.
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Immunoblotting. For analysis of protein expression, cells were har-
vested in RIPA buffer (Sigma) containing protease inhibitor mixture
(Sigma). Proteins were separated on 10% SDS-polyacrylamide gels and
transferred to nitrocellulose membranes. Membranes were blocked for
1 h in 30% Odyssey Blocking Buffer (LI-COR Biosciences) with 0.1%
Tween 20 in PBS, followed by incubation in primary antibodies diluted
in blocking buffer with 0.1% Tween 20 overnight at 4°C. Membranes
were rinsed with 0.1% Tween 20/PBS, followed by incubation with sec-
ondary antibodies diluted in blocking solution for 1 h at room tempera-
ture. After final rinses, blots were scanned with an Odyssey infrared
imager and measurements were obtained using Odyssey software
(LI-COR Biosciences). Primary and secondary antibodies comprised:
mouse monoclonal anti-synaptotagmin 1 (1:1000, clone 41.1; Synaptic
Systems), mouse monoclonal anti-neuroligin 1 (1:1000, clone 4C12;
Synaptic Systems), rabbit polyclonal anti-tubulin (1:1000; Sigma), don-
key anti-mouse IRDye 800CW (1:15,000; LI-COR Biosciences), donkey
anti-rabbit IRDye 680 (1:15,000; LI-COR Biosciences), and donkey anti-
goat IRDye 800CW (1:15,000; LI-COR Biosciences,).
Luciferase-3-UTR construct preparation. 3-UTRs were cloned into
the multiple cloning site of psiCHECK-2 vector (catalog #C8021; Pro-
mega). 3-UTR sequences were retrieved from TargetScan and primers
were designed to amplify full-length 3-UTRs. The following primers
were used (F indicates forward; R, reverse): F-Syt1-3-UTR (TTT ACT
CGA GCT TTC TGC ATC TGC CCA CAT AG), R-Syt1-3-UTR (TAA
AGC GGC CGC AAT TCC TAA AGA TCA AGC ACG AGG); F-Nova1-
3-UTR (AATT CTCGAG TGCCCCGATTATACGTCAGATT),
R-Nova1-3-UTR (TTAA GCGGCCGC GATGCTACATGATGAAC-
TAAGCAC); F-Nlgn1-3-UTR (TAT ACT CGA GTT GGC TTT CAA
CTT GGA AGA CTC), R-Nlgn1-3-UTR (TTA TGC GGC CGC TAT
GCC TTC CAA AAC CCA ACT C); R-Syt1-3-UTR_mut (GGT CCT
TAG GAA GTT TGT GCT AC), F-Syt1-3-UTR_mut (GTA GCA CAA
ACT TCC TAA GGA CC); R-Nova1_mut1 (GAC TCC ATG GAT AGA
CCT TTG TTG), F-Nova1_mut1 (CAA CAA AGG TCT ATC CAT GGA
GTC); R-Nova1_mut2 (TTT AGA GAT AGA TTT CTC TAA ATG),
F-Nova1_mut2 (CAT TTA GAG AAA TCT ATC TCT AAA); F-Nlgn1-
3-UTR_mut (CAC TCT GAT TAC GTC GAT TGA TTT), R-Nlgn1-3-
UTR_mut (AAATCAATCGACGTAATCAGAGTG); F-Stat3-3-UTR
(TAA ACT CGA GGG AGC TGA AAG CGG AAA CTG C), R-Stat3
3-UTR (ATT AGC GGC CGC CTG GAT GTT AAA GTA GTT ACA
GCA); F-Erbb4-3-UTR (TAT ACT CGA GCC AGT AGT TTT GAC
ACT TCC G), R-Erbb4-3-UTR (ATT AGC GGC CGC AGC ATT TGT
TTC ATA TTT TAT TGA ATT); F-Hes5-3-UTR (TAA ACT CGA GAC
GGG TGCCTGGAGCTGAC), R-Hes5 3-UTR (ATT AGCGGCCGC
GAA GCC TTC AGA ACA GCT TGT G); F-Mef2C-3-UTR (TAT TCT
CGA GCT CTC TGA AGG ATG GGC AAC AT), R-Mef2C-3-UTR
(TTA TGC GGC CGC AAA ACA TTA CTA CAA GGC AGG CAG);
F-Neurog1-3-UTR (TAA ACT CGA GCC TTT GCA AGA CAA CGT
TAA T), R-Neurog1-3-UTR (ATT AGC GGC CGC CTT TGA TAG
CTC ATA ATA ATA GAA).
Luciferase reporter assays. The 3-UTR sequences of the target mRNAs
were cloned into the psiCHECK-2 vector (Promega). Five nanograms of
the 3-UTR–psi-CHECK-2 construct was cotransfected with 500 ng of a
lentiviral vector encoding a miRNA gene into human embryonic kidney
293T (HEK293T). Two days after the transfection, luciferase activity was
measured using theDual-Luciferase assay kit (Promega) according to the
manufacturer’s instructions. Luminescence was measured on a Tecan
Genios Pro plate reader in the linear range of the instrument.
Results
Individual neural cell types have distinct miRNA
expression profiles
To address the question of which cell-type-specific miRNAs
might play important roles in neural cell subtype specification
and maintenance, we first comprehensively evaluated the extent
to which the four distinct neural cell types differ in their expres-
sion of miRNAs. To our knowledge, full genome-wide profiling
comparing miRNA expression in neurons, astrocytes, oligoden-
Table 1. Cell-type-restrictedmiRNAs considering four cell subtypes
Cell type Specifically enriched miRNAs Specifically diminished miRNAs
Neurons miR-124, miR-127, miR-129, miR-129*, miR-136, miR-136*, miR-137, miR-154,
miR-300-3p, miR-323, miR-329, miR-341, miR-369-5p, miR-376a, miR-376b-3p,
miR-376c, miR-379, miR-382, miR-382*, miR-410, 411, miR-433, miR-434,
miR-495, miR-541, miR-543*, miR-551b
miR-21, miR-142-3p, miR-142-5p, miR-146a, miR-150, miR-219-2-3p,
miR-223, miR-449a
Astrocytes miR-143, miR-449a miR-327
Oligodendrocytes miR-219-2-3p —
Microglia miR-126, miR-126*, miR-141, miR-142-3p, miR-142-5p, miR-146a, miR-150,
miR-200c, miR-223
miR-9, miR-9*, miR-124, miR-127, miR-129, miR-129*, miR-135a, miR-135b,
miR-136, miR-137, miR-153, miR-204, miR-325-3p, miR-335, miR-384-5p
Shown aremiRNAs specifically enriched or diminished in one cell type comparing neurons, astrocytes, oligodendrocytes, andmicroglia using the criteria of aminimum fivefold difference compared with the average expression in the other
three types and aminimum twofold difference comparedwith any single cell type, differential expression using a statistical cutoff of FDR p 0.01, and including a filter that enrichedmiRNAs be detected as present in all replicate samples
of that cell type. For further details, please see Materials and Methods.
Table 2. Cell-type-restrictedmiRNAs considering neurons, astrocytes, and oligodendrocytes only
Cell type Specifically enriched miRNAs Specifically diminished miRNAs
Neurons miR-7b, miR-124, miR-124*, miR-127, miR-128, miR-129, miR-129*, miR-132, miR-135b,
miR-136, miR-136*, miR-137, miR-139-5p, miR-154, miR-184, miR-188, miR-204,
miR-299, miR-300-3p, miR-300-5p, miR-323, miR-329, miR-337, miR-335, miR-341,
miR-369-3p, miR-369-5p, miR-376a, miR-376a*, miR-376b-3p, miR-376b-5p,
miR-376c, miR-377, miR-379, miR-379*, miR-382, miR-382*, miR-409-5p, miR-410,
miR-411, miR-431, miR-433, miR-434, miR-451, miR-466b, miR-485, miR-495,
miR-539, miR-541, miR-543*, miR-551b, miR-758, miR-873
miR-15b, miR-17-3p, 17-5p, miR-18a, miR-19a, miR-20a, miR-20a*,
miR-21, miR-32, miR-92a, miR-93, miR-142-3p, miR-142-5p,
miR-146a, miR-199a-3p, miR-219-2-3p, miR-219-5p, miR-223,
miR-325, miR-338, miR-350, miR-484, miR-542-3p
Astrocytes miR-21, miR-31, miR-34b, miR-34c, miR-135a, miR-143, miR-146a, miR-193, miR-210,
miR-221, miR-222, miR-223, miR-449a
miR-128, miR-46b, miR-127, miR-551b, miR-188, miR-137, miR-327,
miR-124, miR-494
Oligodendrocytes miR-17-3p, miR-20a, miR-20b-5p, miR-219-2-3p, miR-219-5p, miR-322*, miR-338, miR-
338*, miR-346, miR-351, miR-450a, miR-503, miR-542-3p
miR-449a, miR-204, miR-222, miR-135a
Shown aremiRNAs specifically enriched or diminished in one cell typewhen comparing only neurons, astrocytes, and oligodendrocytes using the criteria of aminimum fivefold difference comparedwith the average expression in the other
two types and a minimum twofold difference compared with any single cell type, differential expression using a statistical cutoff of FDR p 0.01, and including a filter that enriched miRNAs be detected as present in all replicate samples
of that cell type. For further details, please see Materials and Methods.
5130 • J. Neurosci., March 20, 2013 • 33(12):5127–5137 Jovicˇic´ et al. •miRNAs Identify Determinants of Neuronal Phenotypes
drocytes, andmicroglia had never before been reported. Previous
studies had instead compared the miRNA expression in whole
brain tissue with the expression in other tissues of the same or-
ganism (Sempere et al., 2004; Wienholds et al., 2005) or assessed
differences inmiRNA expression during different stages of devel-
opment of individual neural cell types (Krichevsky et al., 2003;
Smirnova et al., 2005; Zhao et al., 2010).
We therefore undertook neural cell-type-specific miRNA ex-
pression analyses in primary cultures derived from P1 rat cortex
(see Materials and Methods). The cellular composition of these
cultures was verified by immunocytochemistry using antibodies
against well established cell-type-specific marker antigens:
NeuN/Rbfox (neuronal nuclear antigen/RNA binding protein
Fox) for mature neurons, GFAP (glial fibrillary acidic protein)
for astrocytes, O4 antigen for oligodendrocytes, and integrinM
chain (Itgam) for microglia (Kuhn et al., 2011). In addition, we
measured the relative expression levels of known cell-type-
specific mRNAs for each of the 4 cell populations: -3 tubulin
(Tuj1) for neurons, Gfap for astrocytes, myelin basic protein
(Mbp) for oligodendrocytes, and Itgam for microglia. These
mRNA expression values indicated largely segregated expression
of the cell-type-specific RNAs, further confirming that the pri-
mary cultures used for expression analyses represented the in-
tended cell populations (Fig. 1). We subsequently performed
expression profiling analyses of 351miRNAs using Agilent Tech-
nologies Rat Genome V1 microarrays. These analyses showed
that neural cell types have remarkably distinctmiRNA expression
profiles (Fig. 2), with 116 of the examined 351 miRNAs being at
least fivefold differentially expressed across the four cell types.
We then used the following criteria to identify individual
miRNAs that were specifically enriched or diminished in individ-
ual cell types: themiRNAs had to have at least a fivefold difference
in expression in one cell type compared with the average expres-
sion in the other three and at least a twofold difference compared
with any other individual cell type, the expression change had to
meet a statistical cutoff of false-discovery rate-adjusted (FDR)
p 0.01, andmiRNAs to be considered enriched in a cell type had
to be reliably detected (called “present” by the Bioconductor
package “limma” (Wettenhall and Smyth, 2004) in all of the rep-
licate samples of that cell type. This analysis yielded multiple
enriched or diminished miRNAs for neurons and microglia and
relatively fewermiRNAs detected as uniquely enriched or dimin-
ished in astrocytes or oligodendrocytes (Table 1).
Figure 3. miRNAs identified as being differentially expressed in primary cultures demon-
strate the same differential expression in vivo. A,B, Thy1 neuronal cells (confirmed by Tubb3
enrichment,A)were isolated frommouse brain using FACS fromThy1-EGFPmice (seeMaterials
and Methods). FACS-isolated cellular RNA from EGFP and EGFP cells was used to confirm
the neuron-enriched expression of miR-124 (positive control), miR-376a, and miR-434 and
neuron-diminished expression ofmiR-146a,miR-19, andmiR-223 (B). Relative expression val-
ues normalized to Actb (Tubb3mRNA) or sno U6 RNA (miRNAs) are shownwith respective SEM.
*p 0.05 by unpaired t test comparing EGFP and EGFP samples. C, D, Gfap astrocytes
(confirmed by Gfap enrichment, C) were isolated frommouse brain using FACS fromGfap-EGFP
mice (seeMaterials andMethods); FACS-isolated cellular RNA confirmed the astrocyte-enriched
expression of miR-143, miR-193, and miR-449a and the astrocyte-diminished expression of
miR-327 and miR-494 (D). Relative expression values normalized to Actb (Gfap mRNA) or sno
U6 RNA (miRNAs) are shownwith respective SEM. *p 0.05; ***p 0.005 by unpaired t test
comparing EGFPwith EGFP samples.
Figure 4. Genomic colocalization and coexpression of neural cell-type-specific miRNAs.
Clusters ofmiRNAs showing cell-type-specific expression (see also Results, Genomic colocaliza-
tion and coexpression of neural cell-type-specific miRNAs). The microglia-enriched cluster on
the Chr4q42 comprises rno-miR-141 and miR-200c. The neuron-enriched clusters on Chr6q32
consist of theRtl1 cluster (comprising rno-miR-127,miR-136,miR-337,miR-431, andmiR-433)
and themiR-379-410 cluster (comprisingmiR-134, miR-136, miR-154, miR-300-3p, miR-300-
5p, miR-323, miR-329, miR-369-3p, miR-369-5p, miR-376a, miR-376a*, miR-376b-3p, miR-
376b-5p,miR-376c,miR-377,miR-379,miR-379*,miR-382,miR-382*,miR-409-5p,miR-410,
miR-411,miR-434,miR-485,miR-487b,miR-494,miR-495,miR-539,miR-541,miR-543*, and
miR-758). The astrocyte-enriched cluster on Chr8q24 comprises rno-miR-34b andmiR-34c. The
neuron-diminished cluster on Chr15q24 comprises rno-miR-17-3p, miR-17-5p, miR-18a, miR-
19a, miR-20a, miR-20a, and miR-92a. The astrocyte-enriched cluster on ChrXq12 comprises
rno-miR-221 andmiR-222 and the neuron-diminished cluster on ChrXq36 comprises rno-miR-
322, miR-322*, miR-351, miR-450a, miR-503, miR-542-3p, and miR-542-5p.
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To focus our analyses on the identifi-
cation of miRNAs that could have impor-
tant roles in neural cell type specification,
we subsequently restricted our analyses to
the differences in neurons, astrocytes, and
oligodendrocytes, which develop from the
sameneural progenitor cells. Applying the
same criteria as in the previous analyses
(at least a fivefold difference in expression
in one cell type comparedwith the average
expression in the other two and a at least a
twofold difference compared with any
other individual cell type, expression
change meeting a statistical cutoff of FDR
p  0.01, and miRNAs to be considered
enriched in a cell type being called “pres-
ent” in all of the replicate samples of that
cell type), we identified 53 enriched and 23 diminished miRNAs
in neurons, 13 enriched and 9 diminished miRNAs in astrocytes,
and 13 enriched and 4 diminished miRNAs in oligodendrocytes
(Table 2).
Toaddress the issue that cell culturesderived fromneonatalbrain
may still be in the process of development (and therefore not repre-
sentative of mature phenotypes in the in vivo context), we further
validated the differential expression of selected miRNAs in
cells acutely isolated from mouse brain. By using FACS on brain
samples of mice expressing EGFP under the control of the Thy1
promoter, we were able to successfully separate neurons from
glial cells as confirmed by enrichment of neuronal marker Tubb3
and neuronal miR-124 in Thy1 cells compared with Thy1
cells (Fig. 3A). These studies confirmed the neuron-enriched ex-
pression of miR-376a and miR-434 and the neuron-diminished
expression of miR-223, miR-146a, and miR-19a (Fig. 3B). By
implementing the same approach using Gfap-EGFP transgenic
mice, we likewise confirmed the astrocyte-enriched expression of
miR-143, miR-193, and miR-449a and the astrocyte-diminished
expression ofmiR-327 andmiR-494 (Fig. 3C,D). These data sup-
port the applicability of our results to intact brain tissues.
Genomic colocalization and coexpression of neural cell-type-
specific miRNAs
miRNAs are frequently found in genomic clusters (Bartel, 2009).
The largest miRNA cluster discovered to date consists of 50
miRNAs in the human imprinted 14q32 domain (Seitz et al.,
2004), which has orthologous clusters in the rat (6q32) and
mouse (12qF1). Interestingly, a few miRNAs within this cluster
have been implicated in regulating synapse-specific genes
(Schratt et al., 2006) and shown to exhibit neuronal-activity-
dependent expression (Fiore et al., 2009). Because miRNAs
found in some genomic clusters have been reported previously to
be subject to coordinated transcriptional control, we investigated
whether miRNAs within clusters exhibited similar expression
patterns across the four neural cell types. We therefore assessed
the extent to which the coexpression of neural cell-type-specific
miRNAs might reflect their genomic colocalization. Among the
miRNAs exhibiting cell-type-specific expression among the four
cell types, only 3 clusters were detected: a microglia-enriched
cluster on Chr4q42 comprising miR-141 and miR-200c and two
neuron-enriched clusters on Chr6q32 (the Rtl1 cluster compris-
ing miR-127, miR-136, miR-337, miR-431, and miR-433 and
the miR-379-410 cluster comprising miR-134, miR-136, miR-
154, miR-300-3p, miR-300-5p, miR-323, miR-329, miR-369-3p,
miR-369-5p, miR-376a, miR-376a*, miR-376b-3p, miR-376b-
5p, miR-376c, miR-377, miR-379, miR-379*, miR-382, miR-
382*, miR-409-5p, miR-410, miR-411, miR-434, miR-485, miR-
487b, miR-494, miR-495, miR-539, miR-541, miR-543*, and
miR-758; Fig. 4). Comparing differentialmiRNA expression only
across neurons, astrocytes, and oligodendrocytes, four additional
clusters were found: two neuron-diminished clusters on Chr15q24
comprisingmiR-17-3p,miR-17-5p,miR-18a,miR-19a,miR-20a,miR-
20a*, andmiR-92a and on ChrXq36 comprising miR-322, miR-322*,
miR-351, miR-450a, miR-503, miR-542-3p, miR-542-5p, and two
astrocyte-enrichedclustersonChrXq12comprisingmiR-34bandmiR-
34c andonChr8q24 comprisingmiR-221 andmiR-222.
Evidence for alternate strand utilization among
neural miRNAs
miRNA biogenesis is a complex process comprising several
intermediate RNA products. It starts with transcription and
genesis of a long primary miRNA, which typically consists of a
Figure5. miRNA strandutilizationdiffers across neural cell subtypes. For eachmiRNA, theAvalues from themicroarray analysis
of miRNA expression in the four cell types are shown. N indicates neurons; A, astrocytes; O, oligodendrocytes; and M, microglia.
Error bars representing SD are containedwithin the data symbols. Data are presented formiR-125-3p/-5p (A),miR-138/-138* (B),
and miR-99b/-99b* (C).
Figure 6. Effects of cell-type-selectivemiRNAs on neural stem cell differentiation. A, Neural
stem cell cultures before differentiation labeledwith anti-nestin antibody. Scale bar, 15m.B,
Neural cultures after FGF withdrawal and differentiation labeled with anti-Tuj1 antibody
(against Tubb3 protein). Scale bar, 15m. C, Overexpression of neuron-enrichedmiRNAsmiR-
124,miR-434, andmiR-376a via lentivirus-mediated transduction inneural stemcells increases
the number of Tuj1 cells, whereas overexpression of glial-enriched miRNAs miR-223, miR-
146a, miR-19a, and miR-32 in neural stem cells decreases the number of Tuj1 cells. Control
samples comprised parallel cultures not exposed to lentiviral vectors. Themean of 15 indepen-
dent replicates is shown; error bars represent SEM. **p 0.01 by unpaired t test compared
with control.
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33 bp double stranded stem with a loop
structure and long single stranded RNA
flanking regions (Siomi and Siomi,
2009). Primary miRNAs are then recog-
nized and cleaved by the Microprocessor
complex to generate precursor miRNA
hairpins (pre-miRNAs) that are 	65–70
nt long. Pre-miRNAs are subsequently ex-
ported to the cytoplasm via exportin5-
RanGTP and further processed in the
cytoplasm by Dicer, which yields an
	22 bp miRNA–miRNA* duplex. This
miRNA duplex is then loaded onto the
Argonaute (Ago) protein, which degrades
one strand (the passenger strand) of the
duplex while the other strand (the guide
strand and mature miRNA) stays associ-
ated with Ago to generate RNA-induced
silencing complexes. The small RNA
cloning strategy used to identify mature
miRNAs revealed that the process of the
strand selection byAgo is not symmetrical
(Lim et al., 2003). Studies investigating
the relative thermodynamic stability of
the two ends of the pre-miRNA duplex
indicated that the strand in which the 5
end is less tightly paired to its complement
remains associated with Ago and per-
forms the functions of thematuremiRNA
(Khvorova et al., 2003; Schwarz et al.,
2003). By convention, the strand that is
more frequently found to be the final
product is referred to as miRNA and the
rarer partner as miRNA*. Alternatively,
when their relative persistence in the cell is
unknown, they are denoted as miRNA-5p
(5-arm) and miRNA-3p (3-arm). To
assess the plausibility of whether “arm
switching” may be used in neural miRNAs,
we considered the relative distributions of
individual members of miRNA–miRNA*
andmiRNA-5p–miRNA-3pmiRNA du-
plex pairs. Of 43 duplex pairs we identi-
fied among our differentially expressed
miRNAs, 39 showed correlated expression
in which one of the two strands was always
present at higher levels, but the relative ex-
Figure 7. Neuron-enriched miRNAs negatively regulate 3-UTRs of genes that would otherwise promote glial development,
whereas glia-enriched miRNAs negatively regulate 3-UTRs of genes that would otherwise promote neuronal development. A,
Neuron-like PC12 cell line shows enriched expression of neuronalmiRNAs comparedwith glia-like C6 cells. *p 0.05; **p 0.01
by unpaired t test comparing PC12 and C6 RNA samples. B, Glia-like cell line C6 shows enriched expression of neuronal miRNAs
compared with glia-like C6 cells. *p 0.05; **p 0.01 by unpaired t test comparing C6 and PC12 RNA samples. C, Neuron-
enrichedmiRNAs are successfully diminished by LNA antagomir transfection in PC12 cells. **p 0.01; ***p 0.001 by unpaired
t test compared with control LNA-transfected cells. D, Glia-enrichedmiRNAs are successfully diminished by LNA antagomir trans-
fection in C6 cells. **p 0.01 by unpaired t test compared with control LNA-transfected cells. E, Overexpression of neuron-
enriched miR-124 or miR-434 negatively regulates the 3-UTR of the Stat3 mRNA. F, Overexpression of miR-223 negatively
4
regulates the Mef2c 3-UTR. G, Antagomirs against miR-124
or miR-434 positively regulate the 3-UTR of the Stat3 mRNA.
H, An antagomir against miR-223 positively regulates the
Mef2c 3-UTR. I, Overexpression of neuron-enriched miR-
376a negatively regulates the 3-UTR of the Hes5 mRNA. J,
Overexpression of miR-19a negatively regulates the Neurog1
3-UTR. K, Antagomir against miR-376a positively regulates
the 3-UTR of the Hes5 mRNA. L, Antagomir of miR-19a posi-
tively regulates the Neurog1 3-UTR. For E–L, **p 0.01 by
unpaired t test comparedwith control miRNA- or control LNA-
treated cells. Results shown are the mean of 6 independent
replicates, error bars represent SD. The additional control
shown in E, F, I, and J was transfected with empty pcDNA3.1
plasmid vector.
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pressionof the two strands acrossneural cell
types retained the same profile. Interest-
ingly, however, there were three miRNA–
miRNA* pairs that were found to have
opposite expression patterns (i.e., they
maintained a different strand in microglia
compared with the other three cell types).
These pairs are as follows: miR-125-5p/
miR-125-3p,miR-138/miR-138*, andmiR-
99b/miR-99b* (Fig. 5). These data support
the hypothesis that the relative strand utili-
zation of some miRNAs are dependent on
the cell type and not purely on the thermo-
dynamic stability of their miRNA-miRNA*
hairpin duplex (Chiang et al., 2010).
Neuron- or glia-enrichedmiRNAs
promote their respective differentiation
programs in neural stem cells
Although neurons, astrocytes, and oligo-
dendrocytes develop from the same stem
cells, they fulfill highly specialized and distinct functions in the
mature nervous system. Having observed that their miRNA pro-
files were also very divergent, we continued the pursuit of our
hypothesis to determine whether these newly identified differen-
tially expressedmRNAsmight have important roles in neural cell
specification. We tested this hypothesis for several miRNAs that
showed either high enrichment or exclusion in neurons: neuron-
enriched miRNAs comprised miR-124, miR-367a, and miR-434
and glial-enriched miRNAs comprised miR-223, miR-19, miR-
32, and miR-146a. We overexpressed the selected miRNAs in rat
cortical stem cells using lentiviral-vector-based gene delivery. To
exclude the possibility that an absence of a miRNA effect on stem
cell differentiationwas due to its failure to be expressed by transduc-
tion with the lentiviral vector, we confirmed the overexpression of
eachmiRNA using qPCR. In some cases, high overexpression levels
led to a decrease in stem cell numbers and therefore confounded a
definitive experimental conclusion. Therefore, we decreased the
concentration of the applied vector to limit overexpression levels of
each miRNA to a maximum of 100-fold compared with endoge-
nous. In addition, we did not take into consideration any data from
treatments that decreased the numbers of cells to35%of the non-
infected control.
Three days after exposure of neural stem cells to the desired
miRNA-expressing lentiviral vector (when the desired expression
levels of miRNAs were attained), we induced stem cell differentia-
tion by FGF withdrawal (see Materials and Methods) and, after an
additional 3d, evaluated the fractionof cells differentiating intoneu-
rons by comparing the number of Tuj1 cellswith the total number
of cells assessed by Hoechst staining. Examples of cell morphology
before and after FGF withdrawal are shown in Figure 6, A and B.
Effects of the selectedmiRNAsonneural stemcell differentiation are
shown in Figure 6C. These results show that several miRNAs had
strong effects on neural stem cell differentiation. As a positive con-
trol, we showed that neuronalmiR-124 increased the differentiation
of stem cells toward neuronal cell fate, in agreement with previous
observations (Krichevsky et al., 2003). Of our newly identified
neuron-enriched miRNAs, miR-376a and miR-434 also increased
the number of cells differentiating toward a neuronal phenotype,
with an effect size similar to miR-124 (Fig. 6C).
Compared with neuron-enriched RNAs, glia-enriched
miRNAs had the opposite effect on proneuronal differentiation.
Several glia-enrichedmiRNAs decreased the number of stem cells
differentiating into neurons, which was apparent by a decreased
fraction of Tuj1 cells (Fig. 6C).
To identify molecular mechanisms by which these miRNAs
regulate cell specification, we considered which of the mRNA
targets of these miRNAs would be involved in neuronal or glial
differentiation. Using the TargetScan algorithm (Lewis et al.,
2005) we found several target predictions for genes with a clear
functional role in neural stem cell differentiation and tested these
target predictions using 3-UTR luciferase assays. For these ex-
periments, we implemented neuron-like (PC12) and glia-like
(C6) cell lines, which were determined to have the same relative
expression of neuron-enriched and glia-enriched (neuron-
diminished) miRNAs (Fig. 7A,B) and in which the correspond-
ing miRNA levels could be diminished by transfection of LNA
antagomirs (Fig. 7C,D). miR-434 negatively regulated the 3-
UTR of the Stat3 mRNA, the targeting of which has been shown
previously to mediate miR-124-dependent proneuronal differ-
entiation of neural stem cells (Krichevsky et al., 2003; Fig. 7E,G).
Similarly, we demonstrated that miR-376a targets Hes5 mRNA,
the negative regulation of which has also been found to promote
neuronal differentiation in other studies (Ohtsuka et al., 1999;
Fig. 7 I,K).
Because glia-enrichedmiRNAshad the opposite effect on pro-
neuronal differentiation, we also identified relevant neuronal tar-
gets. Among the predicted targets for miR-223 and miR-19a, we
confirmed the targeting of Mef2c and Neurog1, which have been
reported to stimulate neuronal differentiation (Fode et al., 2000;
Li et al., 2008; Fig. 7F,H, J,L).
Glia-enrichedmiR-146a targets neuron-specific genes
and functions
In considering the potential targets of various cell-type-specific
miRNAs,we observed that some glia-enrichedmiRNAswere pre-
dicted to target genes known to have important functions in ma-
ture neurons. One such miRNA is miR-146a; GO analysis of the
predicted miR-146a targets (Huang et al., 2008, 2009) showed
significant overrepresentation of GO terms associated with neu-
ron differentiation, axonogenesis, and synaptic transmission.We
therefore sought to examine the functional significance of such
miRNA target pairing. For this purpose, we chose to focus on
three predicted miR-146a targets with neuron-specific expres-
sion and important, well characterized functional roles in neuro-
Figure 8. miR-146a inhibits the expression of neuron-specific targets Nlgn1, Nova1, and Syt1.A, miR-146a inhibits the expres-
sionof luciferase reporter constructs carrying the3-UTRsofNlgn1,Nova1, andSyt1.Deleting theTargetScan-predictedmiR-146a-
binding sites in Nlgn1 and Nova1 3-UTRs abolishedmiR-146a-mediated repression. Mean values of 6 independent replicates are
shown; error bars represent SD. **p 0.01 by unpaired t test compared with control samples transfected with empty pcDNA3.1
vector. B, Western blot experiments showing that miR-146a expression in neurons also inhibits accumulation of endogenous
Nlgn1 and Syt1 proteins.
5134 • J. Neurosci., March 20, 2013 • 33(12):5127–5137 Jovicˇic´ et al. •miRNAs Identify Determinants of Neuronal Phenotypes
nal cells: neuroligin 1 (Nlgn1), neuro-oncological ventral antigen
1 (Nova1), and synaptotagmin 1 (Syt1).
Because sequence-based target prediction alone is subject to
false-positive identification, we first validated that Nlgn1, Nova1,
and Syt1 mRNA 3-UTRs indeed interact with miR-146a using
3-UTR luciferase reporter assays (Fig. 8A). and confirmed for
Nlgn1 and Syt1 that this interaction could lead to a decrease in
endogenous protein levels (Fig. 8B). We also investigated
whether this effect is due to the predicted binding events using
deletion mutants of the identified miR-146a binding sites in the
corresponding 3-UTRs. As predicted, mutations in the Ngln1
and Nova1 3-UTRs abrogated their regulation by miR-146a in
the 3-UTR-luciferase assay, confirming the functionality of the
expected sites (Fig. 8A, first and second panels). Conversely, mu-
tation of the predicted site in the 3-UTR of Syt1 did not abolish
its regulation by miR-146a. Combined with the protein expres-
sion data, this result implies that Syt1 is a target of miR-146a, but
that the actual binding site is different from the predicted one
(Fig. 8A, third panel); alternatively, Syt1 might be an indirect
target of miR-146a.
Given these results, we hypothesized that miR-146a might act
to safeguard against the expression of neuronal genes in glial cells.
It has been shown previously that heterologous expression of key
synaptogenic proteins in non-neuronal cells allows them to re-
ceive projections from neurons and subsequently induce mor-
phological and functional presynaptic differentiation in the
contacting axons (Biederer and Scheiffele, 2007). Neuroligin 1 is
among the neuronal proteins to possess such synaptogenic activ-
ity (Scheiffele et al., 2000; Biederer and Scheiffele, 2007), and we
therefore postulated that the role of miR-146a expression in glia
might be to prevent the formation of inappropriate connections
with neuronal cells. To test this hypothesis, we transfected plas-
mids encoding Nlgn1 with its endogenous full-length 3-UTR or
artificially mutated 3-UTR into primary cortical astrocytes and
assessed the ability of cortical neurons to form synapses onto
transfected astroglial cells. These experiments showed that the
cDNA without the Nlgn1 3-UTR allowed sufficient Nlgn1 ex-
pression to permit synaptogenic activity in adjacent neurons (as
evaluated by quantifying numbers of Syn 1/2 specializations)
(Fig. 9). Conversely, adding back the 3-UTR inhibited theNlgn1
synaptogenic activity (Fig. 9). Moreover, selectively mutating the
miR-146a-binding site restored synaptogenic activity, thereby
supporting a specific role for miR-146a in regulating this pheno-
type. This result indicates that the expression ofmiR-146a by glial
cells safeguards against their producing Nlgn1 and receiving in-
appropriate neuronal projections. By extension, this also implies
that the targeting of other neuronal mRNAs by miR-146a and
other glia-enriched miRNAs might likewise prevent glia from
mistakenly adopting neuron-specific phenotypes.
Discussion
To define the role of anmiRNA, it is crucial to determine both its
molecular targets and its cellular expression. In a neurobiological
context, this issue is important in comparing miRNA-mediated
events in brain with those in other tissues and in identifying
cell-type-specific miRNA functions in brain, which is composed
of distinct cell types that fulfill very different roles. Previous ef-
forts in this area had focused on brain- or neuron-enriched
miRNAs (Lagos-Quintana et al., 2002; Kim et al., 2004; Seitz et
al., 2004; Sempere et al., 2004; Smirnova et al., 2005) or on
miRNAs in which the expression levels changed during neural
cell differentiation (Krichevsky et al., 2003; Lau et al., 2008).
However, a genome-wide investigation of miRNA expression in
neurons, astrocytes, oligodendrocytes, and microglia had not
been available previously.
Our miRNA microarray results are in agreement with previ-
ously published data on single miRNAs with neuron-associated
functions. These include neuronal expression and/or functions
for miR-124 (Lagos-Quintana et al., 2002; Smirnova et al., 2005),
miR-128 (Smirnova et al., 2005), miR-132 (Vo et al., 2005; Klein
et al., 2007;Wayman et al., 2008; Hansen et al., 2010; Impey et al.,
2010),miR-137 (Siegel et al., 2009; Smrt et al., 2010;Willemsen et
al., 2011), miR-184 (Nomura et al., 2008), and the miR379-410
miRNA cluster on chromosome 6 (Seitz et al., 2004). Similarly,
we confirmed the glial expression of miR-219 and miR-338,
which have been implicated previously in the differentiation of
oligodendrocytes (Lau et al., 2008; Dugas et al., 2010; Zhao et al.,
2010), and the astrocyte-enriched expression of miR-21, which
has been reported to be under the transcriptional control of
neuron-restrictive silence factor (NRSF/REST) (Jørgensen et al.,
2009) and aberrantly induced in neurons after traumatic brain
injury (Redell et al., 2011). These results, together with the con-
firmation of the differential expression of 10 newly identified
cell-type-specific miRNAs by FACS-qPCR, support the applica-
bility of our results to other contexts.
Our microarray results showed that the four neural cell types
differ extensively in theirmiRNAprofiles.Moreover, hierarchical
clustering of the expression profiles showed that cell types of
common developmental origin differed least in their miRNA
composition (astrocytes and oligodendrocytes), while neurons
and microglia showed more unique miRNA expression profiles.
These results indicate large differences in miRNA utilization be-
tween cells of neural and hematopoietic lineages. Our data also
provide rationale for future studies of cell-type-specific regula-
Figure 9. miR-146 prevents neurons from forming inappropriate synaptic contacts by targeting the Nlgn1mRNA. Left panels show representativemicrographs. Scale bar, 10m. The graph on
the right represents the number of Syn 1/2punctae per field from5 independent samples, 10 fields per sample. Error bars represent SD. *p 0.05 by unpaired t test comparedwithNlgn1without
its endogenous 3-UTR sequence. CFP indicates cyan fluorescent protein. Scale bar, 10m.
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tion of miRNA expression and processing, given the interesting
finding of alternate miRNA strand utilization in microglial cells.
Because neurons, astrocytes, and oligodendrocytes develop
from the same precursor cells (Gage, 2000), we investigated
whether our novel cell-type-specific miRNAs might play impor-
tant roles in neural stem cell fate determination (Krichevsky et al.,
2003; Le et al., 2009). While confirming that miR-124 is a potent
determinant of neuronal identity (Krichevsky et al., 2003;
Visvanathan et al., 2007), wewere able to significantly expand the
list of miRNAs involved in cell fate specification based on our
newly identified cell-type-enriched miRNAs. We discovered that
miR-434 and miR-376a drive stem cell differentiation toward a
neuronal fate and identified Stat3, Erbb4, and Hes5 as targets in
which negative regulation mediates this effect. Conversely, we
demonstrated that the glia-enriched miRNAs miR-223, miR-
146a, miR-19, and miR-32 were able to inhibit neuronal differ-
entiation, with correspondingmRNA targets includingMef2c for
miR-223 and Neurog1 for miR-19a. In addition to examining
whether other miRNAs discovered to have cell-type-specific ex-
pression might also participate in embryonic neural stem cell
differentiation, we intend to examine the roles of our cell-type-
restricted miRNAs in adult brain neurogenesis in future studies.
The number of neural cell-type-specific miRNAs detected in
our arrays is much larger than the set implicated previously in
brain gene expression. Therefore, our study will be a valuable
resource for future neuroscience miRNA research by delineating
miRNAs expressed in each neural cell type and supporting future
experiments to elucidate cell-type-specific miRNA functions.
In summary, we have found through our comprehensive anal-
yses that levels of specific neural-cell-expressed miRNAs differ
greatly across the four principal brain cell types. In addition to
representing a valuable resource for cell-type-specificmiRNA ex-
pression in brain, our study identifies newmiRNAparticipants in
neural stem cell differentiation and shows that miRNAs can pre-
vent the inappropriate expression of cell-type-specific genes in
fully differentiated cells. These studies therefore provide novel
evidence that cell-type-specific miRNAs have important roles in
both establishing and maintaining distinct neuronal and glial
phenotypes.
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